Novel Mutation in Potassium Channel related Gene KCTD7 and Progressive Myoclonic Epilepsy
Summary Progressive myoclonic epilepsy (PME) is a heterogeneous group of epilepsies characterized by myoclonus, seizures and progressive neurological symptoms. The index patient was a 6‐year old boy showing early‐onset therapy resistant PME and severe developmental delay. Genome‐wide linkage analysi...
Gespeichert in:
Veröffentlicht in: | Annals of human genetics 2012-07, Vol.76 (4), p.326-331 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Summary
Progressive myoclonic epilepsy (PME) is a heterogeneous group of epilepsies characterized by myoclonus, seizures and progressive neurological symptoms.
The index patient was a 6‐year old boy showing early‐onset therapy resistant PME and severe developmental delay. Genome‐wide linkage analysis identified several candidate regions. The potassium channel tetramerization domain containing 7 gene (KCTD7) in the 7q11.21 linkage region emerged as a suitable candidate. Sequence analysis revealed a novel homozygous missense mutation (p.R94W) in a highly conserved segment of exon 2.
This is the second family with PME caused by KCTD7 mutations, hence KCTD7 mutations might be a recurrent cause of PME. |
---|---|
ISSN: | 0003-4800 1469-1809 |
DOI: | 10.1111/j.1469-1809.2012.00710.x |